PrevANZ: Phase IIb Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Trial of Vitamin D3 in Patients with a First Demyelinating Event.

Project: Research

StatusActive
Effective start/end date5/12/1831/12/20